The Life Sciences Dealmaking Symposium 2024 brought together leaders across life sciences to make invaluable connections and hear from key players within the industry on the state of the market and the latest trends and regulatory developments affecting investors and companies.
Check out the key takeaways below for insights from the symposium.
In Depth
Click on the links below to view key takeaways from the Life Sciences Dealmaking Symposium 2024. Key takeaways will be posted as they become available.
- Outcome of the 2024 Election and State of the Market
- The Morning After – Impact of the US Presidential Election on the Deal Environment
- State of the Market – Still Looking for an Exit
- Alternative Capital-Raising Strategies in Challenging Times
- Market Access and Reimbursement – Opportunities and Challenges
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
